Patent · US Active

HER2 binders

US10894097B2 · kind B2 · utility

1Cited by

13References

10Claims

0Family size

Assignees

General Electric Company · US
AFFIBODY AB · SE

Inventors

Faisal Ahmed Syud · Clifton Park, US
Brian Duh-Lan Lee · Rexford, US
Rong Zhang · Zhejiang, CN
Peter Brian Iveson · Norton, GB
Paul Schaffer · Vancouver, CA
Tove Simonsson · Lund, SE
Elin Gunneriusson · Hallsberg, SE
Fredrik Frejd · Stockholm, SE
Lars Abrahmsen · Bromma, SE
Joachim Feldwisch · Tyresö, SE
Nina Herne · Stockholm, SE
Christofer Lendel · Älta, SE

Key dates

Filing date	Sep 27, 2018
Grant date	Jan 19, 2021
Priority date	—
Expiry date	Sep 27, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/71
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Imaging agents comprising an isolated polypeptide conjugated with a radionuclide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.